Evidence map›Paper›PMID 32640653›Full record

ArticleCells2020

Development of Artificial Plasma Membranes Derived Nanovesicles Suitable for Drugs Encapsulation.

Carolina Martinelli, Fabio Gabriele, Elena Dini, Francesca Carriero, Giorgia Bresciani, Bianca Slivinschi, Marco Dei Giudici, Lisa Zanoletti, Federico Manai, Mayra Paolillo and 3 more

Abstract read
In one paragraph

Article in Cells, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Pregnancy-Related Extracellular Vesicles Revisited.International journal of molecular sciences · 2021
    Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Carolina MartinelliDepartment of Biology and Biotechnology, University of Pavia, 27100 Pavia, Italy.
Fabio GabrieleDepartment of Biology and Biotechnology, University of Pavia, 27100 Pavia, Italy.
Elena DiniDepartment of Biology and Biotechnology, University of Pavia, 27100 Pavia, Italy.
Francesca CarrieroDepartment of Biology and Biotechnology, University of Pavia, 27100 Pavia, Italy.
Giorgia BrescianiDepartment of Biology and Biotechnology, University of Pavia, 27100 Pavia, Italy.
Bianca SlivinschiDepartment of Biology and Biotechnology, University of Pavia, 27100 Pavia, Italy.
Marco Dei GiudiciDepartment of Biology and Biotechnology, University of Pavia, 27100 Pavia, Italy.
Lisa ZanolettiDepartment of Biology and Biotechnology, University of Pavia, 27100 Pavia, Italy.
Federico ManaiDepartment of Biology and Biotechnology, University of Pavia, 27100 Pavia, Italy.
Mayra PaolilloDepartment of Drug Science, University of Pavia, 27100 Pavia, Italy.
Sergio SchinelliDepartment of Drug Science, University of Pavia, 27100 Pavia, Italy.
Alberto AzzalinDepartment of Biology and Biotechnology, University of Pavia, 27100 Pavia, Italy.
Sergio CominciniDepartment of Biology and Biotechnology, University of Pavia, 27100 Pavia, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extracellular vesicles (EVs) are considered as promising nanoparticle theranostic tools in many pathological contexts. The increasing clinical employment of therapeutic nanoparticles is contributing to the development of a new research area related to the design of artificial EVs. To this aim, different approaches have been described to develop mimetic biologically functional nanovescicles. In this paper, we suggest a simplified procedure to generate plasma membrane-derived nanovesicles with the possibility to efficiently encapsulate different drugs during their spontaneously assembly. After physical and molecular characterization by Tunable Resistive Pulse Sensing (TRPS) technology, transmission electron microscopy, and flow cytometry, as a proof of principle, we have loaded into mimetic EVs the isoquinoline alkaloid Berberine chloride and the chemotherapy compounds Temozolomide or Givinostat. We demonstrated the fully functionality of these nanoparticles in drug encapsulation and cell delivery, showing, in particular, a similar cytotoxic effect of direct cell culture administration of the anticancer drugs. In conclusion, we have documented the possibility to easily generate scalable nanovesicles with specific therapeutic cargo modifications useful in different drug delivery contexts.

Indexed as

Membranes, ArtificialDrug Delivery SystemsExtracellular VesiclesNanomedicineNanoparticlesMembranes, Artificialdrugs-deliveryextracellular vesiclesnanomedicine

Identifiers

PMID32640653
PMCPMC7408059

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.